|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
increases expression |
ISO |
Homocysteine results in increased expression of ACADM mRNA; Homocysteine results in increased expression of ACADM protein |
CTD |
PMID:26993217 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Ache |
acetylcholinesterase |
increases activity decreases activity |
ISO EXP |
Homocysteine results in increased activity of ACHE protein Homocysteine results in decreased activity of ACHE protein |
CTD |
PMID:16375580 PMID:38729282 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions increases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein] Homocysteine results in increased expression of ACTA2 mRNA; Homocysteine results in increased expression of ACTA2 protein |
CTD |
PMID:21647593 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Ahcy |
adenosylhomocysteinase |
multiple interactions |
ISO |
[Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine |
CTD |
PMID:18487201 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:20305681 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
Folic Acid inhibits the reaction [Homocysteine inhibits the reaction [ALB protein binds to Bilirubin]]; Homocysteine inhibits the reaction [ALB protein binds to Bilirubin] |
CTD |
PMID:33788065 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of APOA1 mRNA; Homocysteine results in decreased expression of APOA1 protein Homocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 mRNA]; Homocysteine inhibits the reaction [Simvastatin results in increased expression of APOA1 protein] |
CTD |
PMID:18540024 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
App |
amyloid beta precursor protein |
increases abundance |
ISO |
APP protein results in increased abundance of Homocysteine |
CTD |
PMID:16837103 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atf1 |
activating transcription factor 1 |
multiple interactions |
EXP |
Homocysteine promotes the reaction [ATF1 protein binds to CCNA2 promoter] |
CTD |
PMID:8550827 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects expression affects localization |
ISO EXP |
BAX protein inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]]; BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine affects the localization of BAX protein]]; Cystathionine inhibits the reaction [Homocysteine affects the localization of BAX protein]; Cystathionine inhibits the reaction [Homocysteine results in increased expression of and affects the localization of BAX protein]; Folic Acid affects the reaction [Homocysteine affects the expression of BAX mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of BAX protein]; Homocysteine results in increased expression of and affects the localization of BAX protein; Zeranol inhibits the reaction [Homocysteine results in increased expression of BAX protein] Homocysteine affects the expression of BAX mRNA; Homocysteine affects the expression of BAX protein Folic Acid inhibits the reaction [Homocysteine results in increased expression of BAX mRNA] |
CTD |
PMID:16757814 PMID:29250709 PMID:31721048 PMID:31885769 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions decreases activity |
EXP |
Folic Acid inhibits the reaction [Homocysteine results in decreased activity of BCHE protein] |
CTD |
PMID:16442260 PMID:38729282 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression affects expression |
ISO EXP |
Folic Acid affects the reaction [Homocysteine affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of BCL2 protein]; Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA; [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein] Homocysteine affects the expression of BCL2 mRNA; Homocysteine affects the expression of BCL2 protein |
CTD |
PMID:16757814 PMID:22169520 PMID:29250709 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of BIRC2 mRNA; Homocysteine results in decreased expression of BIRC2 protein Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 mRNA]; Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC2 protein] |
CTD |
PMID:19343037 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression multiple interactions |
ISO |
Homocysteine results in decreased expression of BIRC3 mRNA; Homocysteine results in decreased expression of BIRC3 protein Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 mRNA]; Simvastatin inhibits the reaction [Homocysteine results in decreased expression of BIRC3 protein] |
CTD |
PMID:19343037 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
affects binding |
EXP |
Homocysteine analog binds to CACNA2D1 protein |
CTD |
PMID:16380257 |
|
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
|
|
G |
Calr |
calreticulin |
increases expression |
ISO |
Homocysteine results in increased expression of CALR mRNA |
CTD |
PMID:26993217 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Casp1 |
caspase 1 |
multiple interactions increases expression increases activity |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; CASP1 protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; PYCARD protein affects the reaction [Homocysteine results in increased activity of CASP1 protein] Homocysteine results in increased expression of CASP1 mRNA |
CTD |
PMID:22647887 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity affects cleavage affects expression |
ISO EXP |
BAX protein inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]]; BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased cleavage of CASP3 protein]]; Cystathionine inhibits the reaction [Homocysteine results in increased activity of and results in increased cleavage of CASP3 protein]; Folic Acid affects the reaction [Homocysteine affects the cleavage of CASP3 protein]; Folic Acid affects the reaction [Homocysteine affects the expression of CASP3 mRNA]; Homocysteine results in increased activity of and results in increased cleavage of CASP3 protein; mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein]; Simvastatin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein] Homocysteine results in increased expression of CASP3 mRNA; Homocysteine results in increased expression of CASP3 protein Atorvastatin inhibits the reaction [Homocysteine results in increased activity of CASP3 protein] Folic Acid inhibits the reaction [Homocysteine results in increased expression of CASP3 protein] |
CTD |
PMID:16715183 PMID:19343037 PMID:20305681 PMID:21237187 PMID:29250709 PMID:31721048 PMID:31885769 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity multiple interactions |
ISO |
Homocysteine results in increased activity of CASP7 protein mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP7 protein] |
CTD |
PMID:21237187 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions affects expression |
ISO |
Folic Acid affects the reaction [Homocysteine affects the expression of CASP8 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of CASP8 protein] Homocysteine affects the expression of CASP8 mRNA; Homocysteine affects the expression of CASP8 protein |
CTD |
PMID:29250709 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO |
BTSA1 compound inhibits the reaction [Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP9 protein]]; Cystathionine inhibits the reaction [Homocysteine results in increased activity of CASP9 protein] |
CTD |
PMID:31885769 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases transport decreases expression multiple interactions decreases activity |
ISO EXP |
CAT protein results in decreased transport of Homocysteine Homocysteine results in decreased expression of CAT protein [CAT gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine Homocysteine results in decreased activity of CAT protein |
CTD |
PMID:12631446 PMID:22964297 PMID:30477822 PMID:38729282 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbs |
cystathionine beta synthase |
affects abundance multiple interactions |
ISO EXP |
CBS protein affects the abundance of Homocysteine; CBS protein affects the abundance of Homocysteine metabolite Homocysteine inhibits the reaction [Folic Acid results in increased activity of CBS protein] |
CTD |
PMID:19204075 PMID:23024785 PMID:31721048 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
[Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein; [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA]; Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] Homocysteine results in increased expression of CCL2 mRNA; Homocysteine results in increased expression of CCL2 protein |
CTD |
PMID:11356643 PMID:16845898 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases expression |
ISO EXP |
[Homocysteine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein Homocysteine results in increased expression of CCL5 protein Ibuprofen inhibits the reaction [Homocysteine results in increased expression of CCL5 protein] Homocysteine results in increased expression of CCL5 mRNA |
CTD |
PMID:16225753 PMID:39357784 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn4 |
cellular communication network factor 4 |
decreases expression |
ISO |
Homocysteine results in decreased expression of CCN4 mRNA |
CTD |
PMID:17320366 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccna1 |
cyclin A1 |
multiple interactions decreases methylation decreases expression |
ISO |
DNMT1 protein affects the reaction [Homocysteine results in decreased expression of CCNA1 mRNA]; Homocysteine inhibits the reaction [MECP2 protein binds to CCNA1 promoter]; Homocysteine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter]; Homocysteine promotes the reaction [H4C16 protein modified form binds to CCNA1 promoter] Homocysteine results in decreased methylation of CCNA1 promoter |
CTD |
PMID:17698632 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions increases expression |
EXP |
Dactinomycin inhibits the reaction [Homocysteine results in increased expression of CCNA2 mRNA]; Homocysteine promotes the reaction [ATF1 protein binds to CCNA2 promoter] Homocysteine results in increased expression of CCNA2 mRNA; Homocysteine results in increased expression of CCNA2 protein |
CTD |
PMID:8550827 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Cdh3 |
cadherin 3 |
multiple interactions decreases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein] Homocysteine results in decreased expression of CDH3 mRNA; Homocysteine results in decreased expression of CDH3 protein |
CTD |
PMID:21647593 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of Homocysteine] |
CTD |
PMID:16758261 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of COX5B protein |
CTD |
PMID:17116298 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of CRK protein |
CTD |
PMID:17116298 |
|
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions increases expression affects localization |
ISO |
CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of ACTA2 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of CDH3 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in increased abundance of Superoxides]; CYBB mutant form inhibits the reaction [Homocysteine results in increased expression of S100A4 protein]; CYBB protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CYBB protein affects the reaction [Homocysteine results in increased abundance of Superoxides]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS1 mRNA]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA]; Filipin inhibits the reaction [Homocysteine affects the localization of CYBB protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine affects the localization of CYBB protein] Homocysteine results in increased expression of CYBB mRNA; Homocysteine results in increased expression of CYBB protein |
CTD |
PMID:20036696 PMID:20116427 PMID:21647593 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
ISO |
[Levodopa co-treated with DDC] results in decreased abundance of Homocysteine |
CTD |
PMID:11445284 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Glycine inhibits the reaction [Homocysteine results in increased expression of DDIT3 mRNA]; Glycine inhibits the reaction [Homocysteine results in increased expression of DDIT3 protein] Homocysteine results in increased expression of DDIT3 mRNA; Homocysteine results in increased expression of DDIT3 protein |
CTD |
PMID:27064126 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Des |
desmin |
multiple interactions increases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; acetovanillone inhibits the reaction [Homocysteine results in increased expression of DES protein]; Amitriptyline inhibits the reaction [Homocysteine results in increased expression of DES protein]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of DES mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased expression of DES protein]; Filipin inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; Filipin inhibits the reaction [Homocysteine results in increased expression of DES protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in increased expression of DES mRNA]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in increased expression of DES protein] Homocysteine results in increased expression of DES mRNA; Homocysteine results in increased expression of DES protein |
CTD |
PMID:20036696 PMID:20116427 PMID:23024785 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
Homocysteine results in increased expression of and results in increased phosphorylation of DNM1L protein; xestospongin C inhibits the reaction [Homocysteine results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:33751715 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases activity multiple interactions |
ISO |
Homocysteine results in decreased activity of DNMT1 protein DNMT1 protein affects the reaction [Homocysteine results in decreased expression of CCNA1 mRNA] |
CTD |
PMID:17698632 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions affects expression |
ISO |
Zeranol inhibits the reaction [Homocysteine affects the expression of EDN1 protein] |
CTD |
PMID:16757814 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
EXP |
Homocysteine results in decreased expression of EGF protein |
CTD |
PMID:39357784 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases phosphorylation |
ISO |
Homocysteine results in decreased phosphorylation of EIF2AK3 protein |
CTD |
PMID:22964297 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
Homocysteine results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:22964297 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ephb6 |
Eph receptor B6 |
decreases expression |
ISO |
Homocysteine results in decreased expression of EPHB6 mRNA |
CTD |
PMID:17320366 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases phosphorylation |
ISO |
Homocysteine results in decreased phosphorylation of ERN1 protein |
CTD |
PMID:22964297 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
decreases expression |
ISO |
Homocysteine results in decreased expression of ERO1A protein |
CTD |
PMID:22964297 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Exosc4 |
exosome component 4 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of EXOSC4 protein |
CTD |
PMID:17116298 |
|
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
|
|
G |
Gata4 |
GATA binding protein 4 |
decreases expression multiple interactions |
EXP |
Homocysteine results in decreased expression of GATA4 mRNA; Homocysteine results in decreased expression of GATA4 protein Particulate Matter promotes the reaction [Homocysteine results in decreased expression of GATA4 protein] |
CTD |
PMID:27203204 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gh1 |
growth hormone 1 |
decreases abundance |
ISO |
GH1 protein results in decreased abundance of Homocysteine |
CTD |
PMID:17311540 PMID:17324600 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
Homocysteine results in increased activity of GPT protein Folic Acid inhibits the reaction [Homocysteine results in increased activity of GPT protein] |
CTD |
PMID:33788065 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity decreases expression |
ISO |
Homocysteine results in decreased activity of GPX1 protein Homocysteine results in decreased expression of GPX1 protein |
CTD |
PMID:15734734 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression |
EXP |
Homocysteine analog results in increased expression of GRIN1 protein |
CTD |
PMID:20406136 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases expression |
ISO |
Homocysteine results in decreased expression of GSR protein |
CTD |
PMID:22964297 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein |
CTD |
PMID:17116298 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
[GSTP1 gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine |
CTD |
PMID:30477822 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H3f4 |
H3.4 histone, cluster member |
multiple interactions |
ISO |
Homocysteine promotes the reaction [H3-4 protein modified form binds to CCNA1 promoter] |
CTD |
PMID:17698632 |
|
NCBI chr10:43,740,702...43,741,262
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO |
Glycine inhibits the reaction [Homocysteine results in increased expression of HSPA5 mRNA] Homocysteine results in increased expression of HSPA5 mRNA; Homocysteine results in increased expression of HSPA5 protein |
CTD |
PMID:19960509 PMID:27064126 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
multiple interactions |
ISO |
Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein]; Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] |
CTD |
PMID:33751715 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
Homocysteine results in increased expression of IL10 mRNA |
CTD |
PMID:38729282 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
EXP |
Homocysteine results in increased expression of IL1B mRNA |
CTD |
PMID:38729282 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression |
EXP |
Homocysteine results in increased expression of IL6 mRNA |
CTD |
PMID:38729282 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
[Alloxan co-treated with Homocysteine] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Homocysteine inhibits the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:27317948 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Isl1 |
ISL LIM homeobox 1 |
affects expression multiple interactions |
ISO |
Homocysteine affects the expression of ISL1 mRNA Folic Acid inhibits the reaction [Homocysteine affects the expression of ISL1 mRNA]; Inositol promotes the reaction [Folic Acid inhibits the reaction [Homocysteine affects the expression of ISL1 mRNA]] |
CTD |
PMID:19638421 |
|
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
increases expression multiple interactions |
ISO |
Homocysteine results in increased expression of ITPR1 protein Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein] |
CTD |
PMID:33751715 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
ISO |
Homocysteine results in increased expression of KEAP1 protein |
CTD |
PMID:22964297 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]]; Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; alpha-methyl-4-carboxyphenylglycine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Cystine affects the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Dizocilpine Maleate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:16251475 PMID:19850060 PMID:25888188 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; Atorvastatin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; diphenyleneiodonium inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; NOX4 mutant form inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:19767766 PMID:20018284 PMID:20305681 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Genistein] inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]]; Go 6976 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Pertussis Toxin inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Phorbol 12,13-Dibutyrate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Phorbol 12,13-Dibutyrate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Thapsigargin promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; alpha-methyl-4-carboxyphenylglycine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Cystine affects the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Dizocilpine Maleate inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16251475 PMID:19850060 PMID:25888188 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
Homocysteine results in increased phosphorylation of MAPK8 protein fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:25888188 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation multiple interactions |
ISO |
Homocysteine results in increased phosphorylation of MAPK9 protein fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:25888188 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcu |
mitochondrial calcium uniporter |
increases expression |
ISO |
Homocysteine results in increased expression of MCU protein |
CTD |
PMID:33751715 |
|
NCBI chr20:27,417,529...27,580,110
Ensembl chr20:27,417,526...27,580,110
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
multiple interactions |
ISO |
Homocysteine inhibits the reaction [MECP2 protein binds to CCNA1 promoter] |
CTD |
PMID:17698632 |
|
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression |
ISO |
Homocysteine results in decreased expression of MFN2 protein |
CTD |
PMID:33751715 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
EXP |
Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of and results in decreased activity of MMP1 protein]; Homocysteine analog results in decreased expression of and results in decreased activity of MMP1 protein |
CTD |
PMID:20406136 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression increases expression increases activity |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of MMP9 protein] Homocysteine results in increased activity of and results in increased expression of MMP9 protein |
CTD |
PMID:16251475 PMID:20406136 PMID:22326992 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions decreases expression |
EXP |
[Folic Acid co-treated with Zinc] inhibits the reaction [Homocysteine results in decreased expression of MT1A mRNA]; Folic Acid inhibits the reaction [Homocysteine results in decreased expression of MT1A mRNA]; Zinc inhibits the reaction [Homocysteine results in decreased expression of MT1A mRNA] |
CTD |
PMID:19641857 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
increases expression multiple interactions affects abundance decreases methylation increases abundance affects metabolic processing |
ISO |
Homocysteine results in increased expression of MTHFR protein [MTHFR gene mutant form co-treated with Methotrexate] results in increased abundance of Homocysteine MTHFR protein affects the abundance of Homocysteine metabolite Homocysteine inhibits the reaction [Simvastatin results in increased expression of MTHFR protein modified form]; Simvastatin promotes the reaction [Homocysteine results in increased expression of MTHFR protein] MTHFR protein SNP results in decreased methylation of Homocysteine MTHFR gene polymorphism results in increased abundance of Homocysteine; MTHFR protein mutant form results in increased abundance of Homocysteine MTHFR protein affects the metabolism of Homocysteine |
CTD |
PMID:7647779 PMID:17387702 PMID:18540024 PMID:19204075 PMID:19593106 PMID:19646848 PMID:20547447 More...
|
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects metabolic processing multiple interactions affects binding |
ISO EXP |
MTR gene polymorphism affects the metabolism of Homocysteine Homocysteine inhibits the reaction [Folic Acid results in increased activity of MTR protein] Homocysteine binds to MTR protein |
CTD |
PMID:17477549 PMID:20532609 PMID:31721048 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
affects abundance |
ISO |
MTRR protein affects the abundance of Homocysteine |
CTD |
PMID:17369066 |
|
NCBI chr 1:34,866,991...34,899,425
Ensembl chr 1:34,867,089...34,899,425
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
affects localization increases phosphorylation multiple interactions |
ISO |
Homocysteine affects the localization of NCF1 protein Homocysteine results in increased phosphorylation of NCF1 protein Filipin inhibits the reaction [Homocysteine affects the localization of NCF1 protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine affects the localization of NCF1 protein] Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of NCF1 protein]; Homocysteine promotes the reaction [NCF1 protein results in increased abundance of Reactive Oxygen Species]; Homocysteine results in increased localization of and results in increased activity of NCF1 protein |
CTD |
PMID:16845898 PMID:17586618 PMID:20036696 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization decreases expression multiple interactions increases expression |
ISO EXP |
Homocysteine affects the localization of NFE2L2 protein modified form Homocysteine results in decreased expression of NFE2L2 protein acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein]; Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein; L 709049 inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein]; N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein]; Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein Homocysteine results in increased expression of NFE2L2 mRNA |
CTD |
PMID:22964297 PMID:38729282 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases degradation |
ISO |
[Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] results in decreased expression of NFKBIA mRNA; [Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein; [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA; acetovanillone inhibits the reaction [Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein]; Folic Acid inhibits the reaction [Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein]; Homocysteine results in increased phosphorylation of and results in increased activity of NFKBIA protein Homocysteine results in increased degradation of NFKBIA protein |
CTD |
PMID:11356643 PMID:16845898 PMID:17586618 PMID:24224954 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
increases degradation |
ISO |
Homocysteine results in increased degradation of NFKBIB protein |
CTD |
PMID:17586618 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nkx2-5 |
NK2 homeobox 5 |
multiple interactions decreases expression |
EXP |
Particulate Matter promotes the reaction [Homocysteine results in decreased expression of NKX2-5 protein] Homocysteine results in decreased expression of NKX2-5 mRNA; Homocysteine results in decreased expression of NKX2-5 protein |
CTD |
PMID:27203204 |
|
NCBI chr10:16,340,428...16,347,004
Ensembl chr10:16,344,159...16,346,934
|
|
G |
Nlrc3 |
NLR family, CARD domain containing 3 |
multiple interactions increases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]] Homocysteine results in increased expression of NLRC3 mRNA |
CTD |
PMID:22647887 |
|
NCBI chr10:11,551,378...11,585,027
Ensembl chr10:11,551,356...11,584,398
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases methylation multiple interactions increases expression |
ISO |
Homocysteine results in increased methylation of NOS2 promoter [Homocysteine results in increased methylation of NOS2 promoter] which results in decreased expression of NOS2 mRNA; Clofibrate inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter]; pioglitazone inhibits the reaction [Homocysteine results in increased methylation of NOS2 promoter] Homocysteine affects the reaction [Simvastatin results in increased expression of NOS2 protein]; Simvastatin promotes the reaction [Homocysteine results in increased expression of NOS2 mRNA] |
CTD |
PMID:17492134 PMID:18540024 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions decreases expression decreases phosphorylation |
ISO |
Folic Acid inhibits the reaction [Homocysteine results in decreased expression of and results in decreased activity of NOS3 protein]; Homocysteine results in decreased expression of and results in decreased activity of NOS3 protein; Zeranol inhibits the reaction [Homocysteine results in decreased expression of NOS3 protein] Atorvastatin inhibits the reaction [Homocysteine results in decreased expression of NOS3 mRNA]; Atorvastatin inhibits the reaction [Homocysteine results in decreased phosphorylation of NOS3 protein] Homocysteine results in decreased expression of NOS3 mRNA; Homocysteine results in decreased expression of NOS3 protein |
CTD |
PMID:16757814 PMID:17357445 PMID:20305681 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions increases response to substance increases expression |
ISO |
Atorvastatin inhibits the reaction [Homocysteine results in increased expression of NOX4 mRNA]; NOX4 mutant form inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK14 protein] NOX4 results in increased susceptibility to Homocysteine |
CTD |
PMID:20018284 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions decreases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS1 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS1 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 mRNA]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS1 protein] Homocysteine results in decreased expression of NPHS1 mRNA; Homocysteine results in decreased expression of NPHS1 protein |
CTD |
PMID:20036696 PMID:20116427 |
|
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
multiple interactions decreases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; Amitriptyline inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; CYBB protein mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of NPHS2 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; Filipin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 mRNA]; methyl-beta-cyclodextrin inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein] Homocysteine results in decreased expression of NPHS2 mRNA; Homocysteine results in decreased expression of NPHS2 protein |
CTD |
PMID:20036696 PMID:20116427 PMID:23024785 |
|
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
|
|
G |
Nt5e |
5' nucleotidase, ecto |
affects activity |
ISO |
Homocysteine affects the activity of NT5E protein |
CTD |
PMID:24055814 |
|
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions decreases expression |
EXP |
Rivastigmine inhibits the reaction [Homocysteine results in decreased expression of NTRK2 protein] |
CTD |
PMID:39357784 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
increases expression |
ISO |
Homocysteine results in increased expression of PACS2 protein |
CTD |
PMID:33751715 |
|
NCBI chr 6:132,096,992...132,156,702
Ensembl chr 6:132,096,901...132,154,583
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
ISO |
[Methionine results in increased abundance of Homocysteine] which results in decreased activity of PON1 protein; [resveratrol results in increased abundance of Homocysteine] which results in decreased activity of PON1 protein |
CTD |
PMID:19028542 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Prdx6 |
peroxiredoxin 6 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of PRDX6 protein |
CTD |
PMID:17116298 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; fulvic acid inhibits the reaction [Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]]; fulvic acid inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]; pyrazolanthrone inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA]; SN50 peptide inhibits the reaction [Homocysteine results in increased expression of PTGS2 mRNA] |
CTD |
PMID:25888188 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions increases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; CASP1 protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]; PYCARD protein affects the reaction [Homocysteine promotes the reaction [NLRC3 protein binds to PYCARD protein binds to CASP1 protein]]; PYCARD protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; PYCARD protein affects the reaction [Homocysteine results in increased activity of CASP1 protein] Homocysteine results in increased expression of PYCARD mRNA |
CTD |
PMID:22647887 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rab1b |
RAB1B, member RAS oncogene family |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of RAB1B protein |
CTD |
PMID:17116298 |
|
NCBI chr 1:202,405,759...202,413,850
Ensembl chr 1:202,405,759...202,413,868 Ensembl chr X:202,405,759...202,413,868
|
|
G |
Rab9a |
RAB9A, member RAS oncogene family |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of RAB9A protein |
CTD |
PMID:17116298 |
|
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression increases localization increases activity |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of RELA protein]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; fulvic acid inhibits the reaction [Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]]; Homocysteine promotes the reaction [RELA protein binds to PTGS2 promoter]; pyrazolanthrone inhibits the reaction [Homocysteine results in increased activity of RELA protein] Homocysteine results in increased expression of RELA protein Homocysteine inhibits the reaction [Simvastatin results in decreased expression of RELA protein] Homocysteine results in increased localization of RELA protein |
CTD |
PMID:17586618 PMID:18540024 PMID:24224954 PMID:25888188 PMID:38729282 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
ISO |
[Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein |
CTD |
PMID:24224954 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
multiple interactions increases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA; [Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein; acetovanillone inhibits the reaction [Homocysteine results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 mRNA]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in increased expression of S100A4 protein]; CYBB mutant form inhibits the reaction [Homocysteine results in increased expression of S100A4 protein] Homocysteine results in increased expression of S100A4 mRNA; Homocysteine results in increased expression of S100A4 protein |
CTD |
PMID:21647593 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
Slc46a1 |
solute carrier family 46 member 1 |
affects abundance |
ISO |
SLC46A1 protein affects the abundance of Homocysteine metabolite |
CTD |
PMID:19204075 |
|
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
EXP |
Homocysteine results in increased expression of SOD1 protein |
CTD |
PMID:17485853 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[SOD2 gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which results in increased abundance of Homocysteine |
CTD |
PMID:30477822 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Ssr4 |
signal sequence receptor subunit 4 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of SSR4 protein |
CTD |
PMID:17116298 |
|
NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions increases expression |
EXP |
Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in increased expression of TIMP1 mRNA]; Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in increased expression of TIMP1 protein] Homocysteine analog results in increased expression of TIMP1 mRNA; Homocysteine analog results in increased expression of TIMP1 protein |
CTD |
PMID:20406136 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression |
ISO |
[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein] Homocysteine results in decreased expression of TJP1 mRNA; Homocysteine results in decreased expression of TJP1 protein |
CTD |
PMID:21647593 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr2 |
toll-like receptor 2 |
decreases expression |
EXP |
Homocysteine results in decreased expression of TLR2 mRNA |
CTD |
PMID:38729282 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein affects the localization of RELA protein modified form]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; [Adenosine co-treated with Homocysteine] affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in increased susceptibility to TNF protein Homocysteine results in increased expression of TNF protein |
CTD |
PMID:24224954 PMID:27203204 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions |
ISO |
[Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; [Adenosine co-treated with Homocysteine] inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 mRNA; [Adenosine co-treated with Homocysteine] results in decreased expression of TNFAIP3 protein |
CTD |
PMID:24224954 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tp53 |
tumor protein p53 |
increases phosphorylation affects expression multiple interactions |
EXP ISO |
Homocysteine results in increased phosphorylation of TP53 protein Homocysteine affects the expression of TP53 mRNA; Homocysteine affects the expression of TP53 protein Folic Acid affects the reaction [Homocysteine affects the expression of TP53 mRNA]; Folic Acid affects the reaction [Homocysteine affects the expression of TP53 protein] |
CTD |
PMID:13679428 PMID:29250709 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vbp1 |
VHL binding protein 1 |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of VBP1 protein |
CTD |
PMID:17116298 |
|
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions increases expression |
ISO |
3,4-dihydroxyphenylethanol inhibits the reaction [Homocysteine results in increased expression of VCAM1 protein]; resveratrol inhibits the reaction [Homocysteine results in increased expression of VCAM1 protein] Homocysteine results in increased expression of VCAM1 mRNA; Homocysteine results in increased expression of VCAM1 protein |
CTD |
PMID:17586618 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
increases expression multiple interactions |
ISO |
Homocysteine results in increased expression of VDAC1 protein Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] |
CTD |
PMID:33751715 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression increases expression decreases secretion |
ISO EXP |
Amitriptyline inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CASP1 protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; CYBB protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein]; diphenyleneiodonium inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein]; Homocysteine results in decreased expression of and results in decreased secretion of VEGFA protein; PYCARD protein affects the reaction [Homocysteine results in decreased secretion of VEGFA protein] Homocysteine results in decreased expression of VEGFA protein Rivastigmine inhibits the reaction [Homocysteine results in decreased expression of VEGFA protein] Homocysteine results in increased expression of VEGFA protein Homocysteine results in decreased expression of VEGFA mRNA |
CTD |
PMID:17485853 PMID:20116427 PMID:22647887 PMID:23024785 PMID:39357784 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
increases expression |
EXP |
Homocysteine results in increased expression of VIM protein |
CTD |
PMID:17485853 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vps29 |
VPS29 retromer complex component |
multiple interactions |
ISO |
[Methionine deficiency co-treated with Homocysteine] affects the expression of VPS29 protein |
CTD |
PMID:17116298 |
|
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
|
|
G |
Wnt5a |
Wnt family member 5A |
decreases expression |
ISO |
Homocysteine results in decreased expression of WNT5A mRNA |
CTD |
PMID:17320366 |
|
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions decreases expression increases expression increases splicing |
ISO |
Glycine affects the reaction [Homocysteine results in increased splicing of XBP1 mRNA] Homocysteine results in decreased expression of XBP1 protein Homocysteine results in increased expression of XBP1 mRNA alternative form |
CTD |
PMID:19960509 PMID:22964297 PMID:27064126 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
EXP |
[homocysteic acid co-treated with GW 506033X] results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:19046382 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
decreases expression |
EXP |
homocysteic acid results in decreased expression of HSF1 protein |
CTD |
PMID:24478344 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Sp1 |
Sp1 transcription factor |
increases activity multiple interactions |
ISO |
homocysteic acid results in increased activity of SP1 protein mithramycin A inhibits the reaction [homocysteic acid results in increased activity of SP1 protein] |
CTD |
PMID:11261509 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sp3 |
Sp3 transcription factor |
multiple interactions increases activity |
ISO |
mithramycin A inhibits the reaction [homocysteic acid results in increased activity of SP3 protein] |
CTD |
PMID:11261509 |
|
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
|
|
|
G |
Ahcy |
adenosylhomocysteinase |
increases hydrolysis |
ISO |
AHCY results in increased hydrolysis of S-Adenosylhomocysteine |
CTD |
PMID:26974671 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases abundance multiple interactions |
ISO |
AHR protein results in increased abundance of S-Adenosylhomocysteine PEMT protein promotes the reaction [AHR protein results in increased abundance of S-Adenosylhomocysteine] |
CTD |
PMID:29416063 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of ALAS2 mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of ALAS2 mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
App |
amyloid beta precursor protein |
increases expression decreases methylation multiple interactions |
ISO |
S-Adenosylhomocysteine results in increased expression of APP protein S-Adenosylhomocysteine results in decreased methylation of APP promoter Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of APP promoter]; Betaine inhibits the reaction [S-Adenosylhomocysteine results in increased expression of and results in increased cleavage of APP protein]; S-Adenosylhomocysteine results in increased expression of and results in increased cleavage of APP protein |
CTD |
PMID:19635394 PMID:22064374 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atp7b |
ATPase copper transporting beta |
increases abundance |
ISO |
ATP7B protein mutant form results in increased abundance of S-Adenosylhomocysteine |
CTD |
PMID:22945834 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Bace1 |
beta-secretase 1 |
increases expression |
ISO |
S-Adenosylhomocysteine results in increased expression of BACE1 protein |
CTD |
PMID:19635394 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of CARM1 protein |
CTD |
PMID:33577917 |
|
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of COL1A1 mRNA |
CTD |
PMID:15983038 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of COL1A2 mRNA |
CTD |
PMID:15983038 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases activity |
EXP |
S-Adenosylhomocysteine results in decreased activity of COMT protein |
CTD |
PMID:10064789 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases activity multiple interactions |
ISO |
S-Adenosylhomocysteine results in decreased activity of DNMT1 protein S-Adenosylhomocysteine inhibits the reaction [DNMT1 protein binds to OGG1 promoter] |
CTD |
PMID:16037419 PMID:22064374 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
decreases abundance |
ISO |
FGF19 protein results in decreased abundance of S-Adenosylhomocysteine |
CTD |
PMID:29416063 |
|
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Hbb |
hemoglobin subunit beta |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HBB mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HBB mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions |
ISO |
[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HMBS mRNA; catechol inhibits the reaction [[S-Adenosylhomocysteine co-treated with Hemin] results in increased expression of HMBS mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
ISO EXP |
S-Adenosylhomocysteine results in increased expression of MMP2 mRNA; S-Adenosylhomocysteine results in increased expression of MMP2 protein S-Adenosylhomocysteine promotes the reaction [SP1 protein binds to MMP2 promoter] U 0126 inhibits the reaction [S-Adenosylhomocysteine results in increased expression of MMP2 protein] |
CTD |
PMID:19770485 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
decreases expression |
EXP |
S-Adenosylhomocysteine results in decreased expression of NFKBIA protein |
CTD |
PMID:19770485 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases abundance |
ISO |
NR0B2 protein results in decreased abundance of S-Adenosylhomocysteine |
CTD |
PMID:29416063 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
multiple interactions decreases methylation decreases expression |
ISO |
Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased expression of OGG1 protein]; Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of OGG1 promoter]; S-Adenosylhomocysteine inhibits the reaction [DNMT1 protein binds to OGG1 promoter] S-Adenosylhomocysteine results in decreased expression of OGG1 mRNA; S-Adenosylhomocysteine results in decreased expression of OGG1 protein |
CTD |
PMID:22064374 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
ISO |
PEMT protein promotes the reaction [AHR protein results in increased abundance of S-Adenosylhomocysteine] |
CTD |
PMID:29416063 |
|
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
ISO |
S-Adenosylhomocysteine results in increased expression of PPARGC1A mRNA |
CTD |
PMID:23056435 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT1 protein |
CTD |
PMID:33577917 |
|
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT5 protein |
CTD |
PMID:33577917 |
|
NCBI chr15:27,968,893...27,978,291
Ensembl chr15:27,968,910...27,978,296
|
|
G |
Prmt6 |
protein arginine methyltransferase 6 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT6 protein |
CTD |
PMID:33577917 |
|
NCBI chr 2:197,927,750...197,932,760
Ensembl chr 2:197,927,220...197,933,648
|
|
G |
Prmt7 |
protein arginine methyltransferase 7 |
decreases activity |
ISO |
S-Adenosylhomocysteine results in decreased activity of PRMT7 protein |
CTD |
PMID:33577917 |
|
NCBI chr19:34,110,724...34,161,531
Ensembl chr19:34,110,747...34,162,577
|
|
G |
Psen1 |
presenilin 1 |
multiple interactions decreases methylation increases expression |
ISO |
Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of PSEN1 promoter] S-Adenosylhomocysteine results in increased expression of PSEN1 protein |
CTD |
PMID:19635394 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
affects abundance |
ISO |
SLC19A1 protein affects the abundance of S-Adenosylhomocysteine |
CTD |
PMID:15705887 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
EXP |
S-Adenosylhomocysteine promotes the reaction [SP1 protein binds to MMP2 promoter] |
CTD |
PMID:19770485 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
decreases expression |
ISO |
S-Adenosylhomocysteine results in decreased expression of TIMP2 protein |
CTD |
PMID:19770485 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|